BlackRock Amends ResMed Stake, Signals Continued Confidence
Ticker: RSMDF · Form: SC 13G/A · Filed: Jan 25, 2024 · CIK: 943819
| Field | Detail |
|---|---|
| Company | Resmed Inc (RSMDF) |
| Form Type | SC 13G/A |
| Filed Date | Jan 25, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**BlackRock still owns a big chunk of ResMed, good sign for the stock!**
AI Summary
BlackRock Inc. filed an amendment (SC 13G/A) on January 25, 2024, disclosing its ownership in ResMed Inc. as of December 31, 2023. This filing, Amendment No. 15, indicates that BlackRock continues to be a significant institutional investor in ResMed, holding common stock. This matters to investors because BlackRock's continued substantial stake signals confidence from one of the world's largest asset managers, which can influence market perception and stability for ResMed stock.
Why It Matters
BlackRock's ongoing significant ownership in ResMed Inc. suggests a long-term institutional belief in the company's value, potentially reassuring current and prospective shareholders.
Risk Assessment
Risk Level: low — This filing is a routine update from a major institutional investor and does not indicate any immediate negative risks for the company.
Analyst Insight
An investor should view this as a routine update from a major institutional holder, confirming BlackRock's continued presence in ResMed. It doesn't signal a new buying opportunity or a reason to sell, but rather reinforces the existing institutional support for the stock.
Key Numbers
- 761152107 — CUSIP Number (identifies ResMed Inc.'s Common Stock)
- 15 — Amendment Number (indicates this is the fifteenth amendment to BlackRock's Schedule 13G for ResMed)
Key Players & Entities
- BlackRock Inc. (company) — the reporting person and institutional investor
- ResMed Inc. (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- January 25, 2024 (date) — the filing date of the SC 13G/A
- Amendment No. 15 (number) — the specific amendment number for this filing
Forward-Looking Statements
- BlackRock will maintain a significant stake in ResMed Inc. (BlackRock Inc.) — high confidence, target: December 31, 2024
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G, filed under the Securities Exchange Act of 1934, specifically Rule 13d-1(b).
Who is the 'reporting person' in this filing?
The reporting person is BlackRock, Inc., as stated under '(1)Names of reporting persons. BlackRock, Inc.' on the cover page.
What is the 'subject company' or 'issuer' of the securities being reported?
The subject company, or issuer, is RESMED INC, as clearly stated in the 'Name of Issuer' section of the Schedule 13G.
What was the 'Date of Event Which Requires Filing of this Statement'?
The date of the event which requires filing of this statement was December 31, 2023, as specified in the filing.
What is the CUSIP number for the securities mentioned in this filing?
The CUSIP number for the Common Stock of ResMed Inc. is 761152107, as listed on the cover page of the Schedule 13G.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 25, 2024 regarding RESMED INC (RSMDF).